Bicara Therapeutics Inc.
BCAX
44 insider filings · Latest: Sep 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Sep 10 8:23 PM | Ryan CohlheppDirector, President, COO & Interim CEO | Sale | 17,500 | $22.90 | $400.7K | 181,641(D) | View → |
| Sep 8, 2026 | Sep 8 8:05 PM | Hyep Ivan | Proposed Sale | 12,500 | $22.64 | $283.0K | — | View → |
| Sep 8, 2026 | Sep 8 8:04 PM | Cohlhepp Ryan | Proposed Sale | 17,500 | $22.64 | $396.2K | — | View → |
| Aug 10, 2026 | Aug 12 8:19 PM | Ivan HyepChief Financial Officer | Sale | 12,500 | $27.97 | $349.6K | 129,855(D) | View → |
| Aug 10, 2026 | Aug 12 8:19 PM | Claire MazumdarDirector, Chief Executive Officer | Sale | 10,000 | $27.98 | $279.8K | 362,152(D) | View → |
| Aug 10, 2026 | Aug 12 8:19 PM | Ryan CohlheppDirector, President and COO | Sale | 18,750 | $27.98 | $524.5K | 181,641(D) | View → |
| Aug 10, 2026 | Aug 10 8:18 PM | Hyep Ivan | Proposed Sale | 12,500 | $27.83 | $347.9K | — | View → |
| Aug 10, 2026 | Aug 10 8:16 PM | Cohlhepp Ryan | Proposed Sale | 18,750 | $27.83 | $521.8K | — | View → |
| Aug 10, 2026 | Aug 10 8:09 PM | Mazumdar Claire | Proposed Sale | 10,000 | $27.83 | $278.3K | — | View → |
| Jul 10, 2026 | Jul 14 8:22 PM | Claire MazumdarDirector, Chief Executive Officer | Sale | 10,000 | $28.42 | $284.2K | 362,152(D) | View → |
| Jul 9, 2026 | Jul 10 8:10 PM | Ryan CohlheppDirector, President and COO | Sale | 536 | $29.00 | $15.5K | 181,641(D) | View → |
| Jul 8, 2026 | Jul 10 8:10 PM | Ryan CohlheppDirector, President and COO | Sale | 28,214 | $28.98 | $817.6K | 182,177(D) | View → |
| Jul 8, 2026 | Jul 10 8:10 PM | Ivan HyepChief Financial Officer | Sale | 28,000 | $28.85 | $807.7K | 129,855(D) | View → |
| Jul 10, 2026 | Jul 10 8:04 PM | Mazumdar Claire | Proposed Sale | 10,000 | $29.68 | $296.8K | — | View → |
| Jul 8, 2026 | Jul 8 8:30 PM | DAVID RABEN | Proposed Sale | 50,000 | $28.56 | $1.4M | — | View → |
| Jul 8, 2026 | Jul 8 8:11 PM | Cohlhepp Ryan | Proposed Sale | 28,750 | $30.25 | $869.7K | — | View → |
| Jul 8, 2026 | Jul 8 8:05 PM | Hyep Ivan | Proposed Sale | 28,000 | $30.25 | $847.0K | — | View → |
| Jul 7, 2026 | Jul 7 8:06 PM | Lara Meisner | Proposed Sale | 1,000 | $29.77 | $29.8K | — | View → |
| Jun 25, 2026 | Jun 25 8:07 PM | DAVID RABEN | Proposed Sale | 50,000 | $26.49 | $1.3M | — | View → |
| Jun 1, 2026 | Jun 1 8:02 PM | Meisner Lara | Proposed Sale | 71,390 | $20.64 | $1.5M | — | View → |
Page 1 of 5
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Mar 6 12:06 AM | David RabenChief Medical Officer | Option Exercise | 200 | $3.79 | 69,213(D) | View → |
| Feb 26, 2026 | Mar 2 9:22 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 2,200,000 | $0.0001 | 2,200,000(I) | View → |
| Feb 25, 2026 | Feb 27 9:13 PM | Ryan CohlheppDirector, President and COO | Option Exercise | 3,108 | $3.79 | 138,226(D) | View → |
| Feb 2, 2026 | Feb 4 9:38 PM | Ryan CohlheppDirector, President and COO | Grant/Award | 300,000 | $16.76 | 300,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:37 PM | Claire MazumdarDirector, Chief Executive Officer | Grant/Award | 450,000 | $16.76 | 450,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:36 PM | David RabenChief Medical Officer | Grant/Award | 100,000 | $16.76 | 100,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:35 PM | Ivan HyepChief Financial Officer | Grant/Award | 125,000 | $16.76 | 125,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:34 PM | Lara MeisnerChief Legal Officer | Grant/Award | 90,000 | $16.76 | 90,000(D) | View → |
| Jan 22, 2026 | Jan 26 9:33 PM | Ivan HyepChief Financial Officer | Option Exercise | 1,882 | $3.79 | 65,462(D) | View → |
← Previous
Page 3 of 3